China To Approve First Covid Monoclonal Antibody Drug By Dec


Source: ommcomnews.com ommcomnews.com

Key Topics in this News Article:

News Snapshot:

World China To Approve First Covid Monoclonal Antibody Drug By Dec By OMMCOM NEWS Last updated Nov 15, 2021 Share Beijing: China is set to approve the country’s first monoclonal antibody combination therapy against Covid-19 by December, according to media reports. Monoclonal antibodies are proteins designed to attach to a specific target, in this case the spike protein of SARS-CoV-2, which the virus uses to enter human cells. The combination therapy is co-developed by Tsinghua University, the Third People’s Hospital of Shenzhen and Brii Biosciences headquartered in China and the US, Global Times reported. It is also likely to be...